Hideo Shichinohe
Overview
Explore the profile of Hideo Shichinohe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
1251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawabori M, Shichinohe H, Kahata K, Miura A, Maeda K, Ito Y, et al.
BMJ Open
. 2024 Dec;
14(12):e083959.
PMID: 39622566
Introduction: Intracerebral haemorrhage (ICH) stands as a leading global cause of death and disability, posing a significant challenge with limited treatment options, especially for chronic patients. Recent advances in stem...
2.
Kawabori M, Kuroda S, Shichinohe H, Kahata K, Shiratori S, Ikeda S, et al.
Med
. 2024 Mar;
5(5):432-444.e4.
PMID: 38547868
Background: Ischemic stroke is one of the leading causes of death and neurological disability worldwide, and stem cell therapy is highly expected to reverse the sequelae. This phase 1/2, first-in-human...
3.
Takamiya S, Kawabori M, Kitahashi T, Nakamura K, Mizuno Y, Yasui H, et al.
Stem Cells Int
. 2022 Aug;
2022:8521922.
PMID: 35966129
Background: Due to the lack of effective therapies, stem cell transplantation is an anticipated treatment for chronic intracerebral hemorrhage (ICH), and higher cell survival and engraftment are considered to be...
4.
Kawabori M, Tanimori A, Kitta S, Shichinohe H, Houkin K
Stem Cells Int
. 2021 May;
2021:9796010.
PMID: 34054971
[This corrects the article DOI: 10.1155/2020/4085617.].
5.
Kawabori M, Shichinohe H, Kuroda S, Houkin K
Int J Mol Sci
. 2020 Oct;
21(19).
PMID: 33036265
Despite recent developments in innovative treatment strategies, stroke remains one of the leading causes of death and disability worldwide. Stem cell therapy is currently attracting much attention due to its...
6.
Tan C, Wang Z, Zheng M, Zhao S, Shichinohe H, Houkin K
J Nippon Med Sch
. 2020 Sep;
88(3):228-237.
PMID: 32863340
Background: Stroke is a leading cause of death and disability worldwide. Recently, secondary damage to the brain has been hypothesized as a key aggravating element in the ischemic cascade. However,...
7.
Kawabori M, Tanimori A, Kitta S, Shichinohe H, Houkin K
Stem Cells Int
. 2020 Feb;
2020:4085617.
PMID: 32104184
Cell therapy for central nervous system (CNS) disorders is beginning to prove its safety and efficiency. Intraparenchymal transplantation can be an option for cell delivery; however, one concern regarding this...
8.
9.
Miyamoto M, Nakamura K, Shichinohe H, Yamauchi T, Ito M, Saito H, et al.
Stem Cells Int
. 2018 May;
2018:4829534.
PMID: 29765415
Bone marrow stromal cell (BMSC) transplantation has the therapeutic potential for ischemic stroke. However, it is unclear which delivery routes would yield both safety and maximal therapeutic benefits. We assessed...
10.
Tan C, Zhao S, Higashikawa K, Wang Z, Kawabori M, Abumiya T, et al.
EJNMMI Res
. 2018 May;
8(1):35.
PMID: 29717383
Background: The potential application of bone marrow stromal cell (BMSC) therapy in stroke has been anticipated due to its immunomodulatory effects. Recently, positron emission tomography (PET) with [F]DPA-714, a translocator...